Cargando…
Aspects of early arthritis. Biological therapy in early arthritis – overtreatment or the way to go?
The availability of newer, and more expensive, therapies for patients with rheumatoid arthritis has changed treatment beyond recognition. Disease remission is the goal for all new patients. Studies have shown that a combination of tumour necrosis factor (TNF)-blocking drugs and methotrexate produces...
Autores principales: | Ikeda, Kei, Cox, Sally, Emery, Paul |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2206357/ https://www.ncbi.nlm.nih.gov/pubmed/17540047 http://dx.doi.org/10.1186/ar2177 |
Ejemplares similares
-
Overtreatment in rheumatoid arthritis: are there reasons for concern?
por: Ferreira, Ricardo J O, et al.
Publicado: (2022) -
Aspects of early arthritis. Traditional DMARD therapy: is it sufficient?
por: Machold, Klaus P, et al.
Publicado: (2006) -
Aspects of early arthritis. What determines the evolution of early undifferentiated arthritis and rheumatoid arthritis? An update from the Norfolk Arthritis Register
por: Symmons, Deborah PM, et al.
Publicado: (2006) -
Aspects of early arthritis. Definition of disease states in early arthritis: remission versus minimal disease activity
por: van der Helm-van Mil, Annette HM, et al.
Publicado: (2006) -
Overdiagnosis and overtreatment of early detected prostate cancer
por: Bangma, C. H., et al.
Publicado: (2007)